Calabadion 1 selectively reverses respiratory and central nervous system effects of fentanyl in a rat model.


Journal

British journal of anaesthesia
ISSN: 1471-6771
Titre abrégé: Br J Anaesth
Pays: England
ID NLM: 0372541

Informations de publication

Date de publication:
07 2020
Historique:
received: 27 11 2019
revised: 23 02 2020
accepted: 25 02 2020
pubmed: 4 4 2020
medline: 14 7 2020
entrez: 4 4 2020
Statut: ppublish

Résumé

We hypothesised that Calabadion 1, an acyclic cucurbit[n]uril molecular container, reverses fentanyl-induced respiratory depression and dysfunction of the CNS. Experiments were conducted in male Sprague-Dawley rats. A constant-rate i.v. infusion of fentanyl (12.5 or 25 μg kg Calabadion 1 reversed fentanyl-induced respiratory depression across the endpoints minute ventilation, pH, and Paco Calabadion 1 selectively and dose dependently reversed the respiratory system and CNS side-effects of fentanyl.

Sections du résumé

BACKGROUND
We hypothesised that Calabadion 1, an acyclic cucurbit[n]uril molecular container, reverses fentanyl-induced respiratory depression and dysfunction of the CNS.
METHODS
Experiments were conducted in male Sprague-Dawley rats. A constant-rate i.v. infusion of fentanyl (12.5 or 25 μg kg
RESULTS
Calabadion 1 reversed fentanyl-induced respiratory depression across the endpoints minute ventilation, pH, and Paco
CONCLUSIONS
Calabadion 1 selectively and dose dependently reversed the respiratory system and CNS side-effects of fentanyl.

Identifiants

pubmed: 32241547
pii: S0007-0912(20)30134-3
doi: 10.1016/j.bja.2020.02.019
pmc: PMC7418560
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Heterocyclic Compounds, 4 or More Rings 0
Sulfonic Acids 0
calabadion 1 0
Fentanyl UF599785JZ

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e140-e147

Subventions

Organisme : NIA NIH HHS
ID : R01 AG053582
Pays : United States
Organisme : NHLBI NIH HHS
ID : UG3 HL140177
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM132345
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA168365
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL117871
Pays : United States

Informations de copyright

Copyright © 2020 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.

Références

Anesthesiology. 2015 Nov;123(5):1093-104
pubmed: 26352381
Org Biomol Chem. 2016 Jan 28;14(4):1277-87
pubmed: 26648135
J Bronchology Interv Pulmonol. 2017 Jan;24(1):e9-e10
pubmed: 27984392
Br J Anaesth. 2005 Jun;94(6):825-34
pubmed: 15833777
Chembiochem. 2017 Aug 17;18(16):1583-1588
pubmed: 28586110
Anesthesiology. 2013 Aug;119(2):317-25
pubmed: 23549405
Chest. 2013 Apr;143(4):1145-1146
pubmed: 23546488
Crit Rev Biomed Eng. 1992;19(4):293-340
pubmed: 1563271
Br J Anaesth. 2019 Jun;122(6):e180-e188
pubmed: 30982564
Annu Rev Neurosci. 2011;34:601-28
pubmed: 21513454
Clin Neurophysiol. 2016 Jun;127(6):2472-81
pubmed: 27178867
Anesthesiology. 2015 Dec;123(6):1337-49
pubmed: 26418697
Anesthesiology. 1989 Aug;71(2):242-9
pubmed: 2569282
Br J Anaesth. 2018 May;120(5):1090-1102
pubmed: 29661386
Br J Clin Pharmacol. 2013 Jan;75(1):60-78
pubmed: 22554450
Br J Anaesth. 1994 Mar;72(3):328-34
pubmed: 8130053
J Am Chem Soc. 2005 Nov 16;127(45):15959-67
pubmed: 16277540
J Pharmacol Exp Ther. 2018 Jul;366(1):105-112
pubmed: 29674333
JAMA. 2018 May 1;319(17):1819-1821
pubmed: 29715347
Ther Adv Drug Saf. 2018 Jan;9(1):63-88
pubmed: 29318006
Anesthesiology. 2015 Mar;122(3):659-65
pubmed: 25536092
Anesthesiology. 1981 Sep;55(3):203-11
pubmed: 7270948
Anesthesiology. 1991 Jan;74(1):34-42
pubmed: 1670913
Anesthesiology. 2016 Aug;125(2):333-45
pubmed: 27341276
Stroke. 1987 Mar-Apr;18(2):503-11
pubmed: 3564110
Sci Rep. 2019 Oct 1;9(1):14122
pubmed: 31575947
Anesthesiology. 2010 Jan;112(1):226-38
pubmed: 20010421
Clin Toxicol (Phila). 2016 Jun;54(5):420-3
pubmed: 26999038
Nat Chem. 2012 Apr 15;4(6):503-10
pubmed: 22614387

Auteurs

Tharusan Thevathasan (T)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.

Stephanie D Grabitz (SD)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Peter Santer (P)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Paul Rostin (P)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.

Oluwaseun Akeju (O)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.

James D Boghosian (JD)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.

Monica Gill (M)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.

Lyle Isaacs (L)

Department of Chemistry and Biochemistry, University of Maryland, College Park, MD, USA.

Joseph F Cotten (JF)

Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA.

Matthias Eikermann (M)

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Klinik für Anästhesiologie und Intensivmedizin, Universität Duisburg-Essen, Essen, Germany. Electronic address: meikerma@bidmc.harvard.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH